Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01908478
Title A Phase I Study of Veliparib (ABT-888) in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Locally Advanced, Unresectable Pancreatic Cancer
Acronym VelGemRad
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.